On the in vitro and in vivo Properties of Four Locked Nucleic Acid Nucleotides Incorporated into an Anti‐H‐Ras Antisense Oligonucleotide
- 30 May 2005
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 6 (6) , 1104-1109
Abstract
Locked nucleic acid (β‐D‐LNA) monomers are conformationally restricted nucleotides bearing a methylene 2′‐O, 4′‐C linkage that have an unprecedented high affinity for matching DNA or RNA. In this study, we compared the in vitro and in vivo properties of four different LNAs, β‐D‐amino LNA (amino‐LNA), β‐D‐thio LNA (thio‐LNA), β‐D‐LNA (LNA), and its stereoisomer α‐L‐LNA in an antisense oligonucleotide (ODN). A well‐known antisense ODN design against H‐Ras was modified at the 5′‐ and 3′‐ends with the different LNA analogues (LNA‐DNA‐LNA gapmer design). The resulting gapmers were tested in cancer‐cell cultures and in a nude‐mouse model bearing prostate tumor xenografts. The efficacy in target knockdown, the biodistribution, and the ability to inhibit tumor growth were measured. All anti H‐Ras ODNs were very efficient in H‐Ras mRNA knockdown in vitro, reaching maximum effect at concentrations below 5 nM. Moreover, the anti‐H‐Ras ODN containing α‐L‐LNA had clearly the highest efficacy in H‐Ras knockdown. All LNA types displayed a great stability in serum. ODNs containing amino‐LNA showed an increased uptake by heart, liver, and lungs as compared to the other LNA types. Both α‐L‐LNA and LNA gapmer ODNs had a high efficacy of tumor‐growth inhibition and were nontoxic at the tested dosages. Remarkably, in vivo tumor‐growth inhibition could be observed at dosages as low as 0.5 mg kg−1 per day. These results indicate that α‐L‐LNA is a very promising member of the family of LNA analogues in antisense applications.Keywords
This publication has 29 references indexed in Scilit:
- Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cellsGene Therapy, 2004
- Synthesis of 2′-amino-LNA: a new strategyElectronic supplementary information (ESI) available: further experimental details and the structure of compound S11 (.pdb file). See http://www.rsc.org/suppdata/ob/b2/b208864a/Organic & Biomolecular Chemistry, 2003
- Preparation of LNA PhosphoramiditesSynthesis, 2002
- α-l-ribo-Configured Locked Nucleic Acid (α-L-LNA): Synthesis and PropertiesJournal of the American Chemical Society, 2002
- α-l-LNA (α-i-ribo Configured Locked Nucleic Acid) Recognition of RNA. A Study by NMR Spectroscopy and Molecular Dynamics SimulationsJournal of the American Chemical Society, 2001
- Making Drugs Out of Oligonucleotides: A Brief Review and PerspectiveNucleosides and Nucleotides, 1999
- Synthesis and restricted furanose conformations of three novel bicyclic thymine nucleosides: a xylo-LNA nucleoside, a 3′-O,5′-C-methylene-linked nucleoside, and a 2′-O,5′-C-methylene-linked nucleosideJournal of the Chemical Society, Perkin Transactions 1, 1999
- LNA stereoisomers: xylo-LNA (β-D-xylo configured locked nucleic acid) and α-L-LNA (α-L-ribo configured locked nucleic acid)Chemical Communications, 1999
- Synthesis of Novel Bicyclo[2.2.1] Ribonucleosides: 2‘-Amino- and 2‘-Thio-LNA Monomeric NucleosidesThe Journal of Organic Chemistry, 1998
- LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognitionChemical Communications, 1998